Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed Growth (1y) (2021 - 2026)
Zentalis Pharmaceuticals (ZNTL) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 470.97 Bn | 466.18 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.05 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.43 Bn | 34.42 Bn | 959.66 Mn | 2,400.00 |
| 10 | Zentalis Pharmaceuticals | 316.89 Mn | 316.89 Mn | - | -224.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -224.00 |
| Dec 31, 2025 | -697.00 |
| Sep 30, 2025 | -440.00 |
| Jun 30, 2025 | -747.00 |
| Mar 31, 2025 | -739.00 |
| Dec 31, 2024 | 1,068.00 |
| Sep 30, 2024 | 175.00 |
| Jun 30, 2024 | 640.00 |
| Mar 31, 2024 | -71.00 |
| Dec 31, 2023 | -1,239.00 |
| Sep 30, 2023 | -678.00 |
| Jun 30, 2023 | -152.00 |
| Mar 31, 2023 | 679.00 |
| Dec 31, 2022 | 643.00 |
| Sep 30, 2022 | 1,992.00 |
| Jun 30, 2022 | 1,317.00 |
| Mar 31, 2022 | -934.00 |
| Dec 31, 2021 | -2,016.00 |
| Sep 30, 2021 | -3,415.00 |
| Jun 30, 2021 | -2,078.00 |